Clinical Trial Update: Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating perioperative propranolol during prostatectomy to decrease cancer recurrence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Oslo University Hospital | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED